A4C News

Angels for Change Founder joins the End Drug Shortages Alliance Board

The #EndDrugShortages Alliance is a new group of stakeholders from across the industry who have come together to put an end to drug shortages. This issue impacts patient care— all too often it’s life-saving care. Angels for Change is proud to be a part of the #EndDrugShortages Alliance and announce that our founder, Laura Bray, is a member of the Board of Directors. Read about the EDSA here.

Issue One of The Changemaker Chronicle

Issue One of The Changemaker Chronicle

Angels for Change is proud to present the first issue of our newsletter, The Changemaker Chronicle. Click below to enjoy recaps of our 2021 events and achievements, and to preview some of our upcoming events and fundraisers.

September 23 Press Release

Press Release:

September 22, 2021 (Tampa, Florida) – 

USP-Vizient-Angels for Change Publication Reveals Essential Pediatric Oncology Drugs are 90% More Likely to Have a Shortage Event than the Average Generic Drug

In May 2021, Angels for Change, U. S. Pharmacopeia (USP) and Vizient collaborated to characterize and quantify supply chain risk for drugs to improve pediatric oncology access to quality medicines. The result of this collaboration, entitled “Quantifying Drivers of Supply Chain Resilience in Pediatric Oncology Medications,” reveals that essential pediatric oncology drugs are 90% more likely to have a shortage event and take 33% longer to resolve than the average generic drug. 

Laura Bray, Founder and Chief Change Maker of Angels for Change said, “4 out of 5 pediatric cancer patients now survive diagnosis. Survival requires medicines to be delivered in a ‘cocktail’ at very specific timings. Drug shortages disrupt these treatments. In the last 5 years, 74% of the essential pediatric oncology drugs have had a shortage event. It is the most vulnerable patients with the smallest voices who  are being left behind.” Bray’s own child experienced multiple drug shortages during her leukemia treatment.

This collaboration is an important step because it provides a scientifically and statistically substantiated review of the attributes often associated with drug shortages. It reveals the importance of data and transparency across supply chain partners in gaining the visibility necessary to collectively address and alleviate factors that lead to shortages.

The white paper highlights four key findings: 1. injectables with lower price points have more vulnerable supply chains; 2. greater geographic concentration decreases supply chain resilience; 3. drugs with higher manufacturing complexity are more vulnerable to supply disruptions; 4. quality failures increase supply chain vulnerability. 

Improving patient access will require prioritization of essential medicines for vulnerable populations, investment in building manufacturing capacity/inventory of essential drugs, incentivization of quality manufacturing, and sharing of data across all stakeholders. 

The study’s insights were based on the output of the USP Drug Supply Chain Resiliency Model. The USP Medicine Supply Map, which includes data points for 89% of generic national drug codes, is the foundation for this model. Machine learning algorithms were applied based on key attributes and shortage records for 19 essential pediatric oncology drugs. This modeling took into account both supply-side and demand-side factors.

The drug shortage crisis can be alleviated by engaging with stakeholders in different parts of the healthcare system to foster multi-disciplinary approaches. It will ultimately require a global effort to prioritize the eradication of drug shortages. Stakeholders across the healthcare spectrum must dedicate the time and resources necessary to bring about change. It won’t happen overnight, but it can and must happen. Enduring solutions will come from collaboration, just like this one.

“As Vizient continues with our mission to end drug shortages, collaboration with organizations like USP and Angels for Change is critical to identifying and addressing those root causes to drug shortages. Transparency continues to be a key step as we progress forward,” says Steven Lucio, PharmD, BCPS, Sr Principal, Vizient Center for Pharmacy Practice Excellence

“It’s critical to understand the upstream pharmaceutical supply chain when assessing potential drug shortages and strategies to avoid them. Having identified vulnerabilities for essential pediatric oncology drugs in collaboration with Angels for Change and Vizient, collective and decisive action should be taken to protect one of our most vulnerable patient populations,” stated Michael Levy, USP's Senior Vice President, Digital & Innovation. 

Angels for Change is a volunteer-run organization on a mission to end drug shortages through advocacy, awareness, and building a more resilient supply chain. We are passionate about building support and awareness to create solutions that will provide equal drug access to patients in need. Our focus is to advocate on behalf of any patient in a drug shortage and build relationships with patients and members of the pharmaceutical supply chain to end the healthcare crises created by drug shortages. 

Press Contacts: Laura Bray, Angels for Change Chief Changemaker LauraBray@AngelsforChange.org

Diane Masiello, Angels for Change, Communications Director communications@angelsforchange.org

September 7 Press Release

Press Release:

September 7, 2021 (Tampa, Florida) 

Inaugural Angels for Change Swim2End Shortages Fundraiser Exceeds Goal

Angels for Change, a Tampa-based non-profit with the goal of ending life-saving drug shortages, held its first fundraiser on August 14, 2021. Called Swim2End Shortages, the event gathered supporters from Brandon, Valrico, Lithia, Bloomingdale, Riverview, and Tampa for a day of family fun. One attendee even drove all the way from where he was visiting his family in The Villages to support the event.

Although the goal was to raise the $8,000 in operating costs that had up until this point been funded by Angels for Change founder Laura Bray and her family, it also aimed to raise community awareness of the organization and its mission. 

“There are patients fighting for their lives and doctors don’t have access to the medications needed to save them,” Bray told the supporters who gathered for the event. “When my daughter was diagnosed with leukemia, I was told there was medicine out there to save her. I never imagined it wouldn’t be available.” 

The event, sponsored by TYR and Watch-Me-Swim, asked participants to either create a swim team and collect donations, or attend as cheerleaders. Entire families registered, as well as adults from fitness group Camp Gladiator. The swimmers were divided by age group. A remote option was also available. 

Winners in three different categories received a fabulous bag of swim gear from TYR. Jillian W. (11) won the in-person swim, Sammy M. (10) won the remote swim, and Camp Gladiator won the team swim. 

After the official event families and other attendees were welcome to continue using the lanes or diving boards to keep the party going. DJ Angel from Sustache Entertainment provided a wonderful soundtrack for the entire morning. 

Though founded in 2019, Swim2End was the organization’s first fundraiser because the Brays, like many families with a child fighting cancer, have been in isolation. Bray and her event committee chose this swim meet as their first event because the Brays are a swimming family, swimming is an outdoor event that allows for social distancing, and because it was important the first event be one the children could be part of. 

Children are at the center of the Angels for Change mission, as drug shortages disproportionately effect pediatric oncology patients. Essential pediatric cancer treatments are 80% more likely to be unavailable because of shortage and to stay on shortage 50% longer than other essential medications. 

When asked what Swim2End meant to him, 10-year-old attendee Johnny A. said, “It means we are helping raise money to help children get the drugs they need to save their lives.” 

Angels for Change has been an advocate for pediatric cancer patients at risk of not getting life-saving drugs. In the last 15 months Angels for Change has helped more than 50 patients whose treatment was delayed because of drug shortages. 

Patients and doctors who are having trouble accessing these drugs, or patients who have been put on hold or are missing doses, can contact Angels for Change at www.angelsforchange.org for support.

Angels for Change is a volunteer-run organization on a mission to drive change, through advocacy and awareness, of the life-saving drug shortage crisis. We are passionate about building support and awareness to create solutions that will provide equal drug access to patients in need. Our focus is to advocate on behalf of any patient in a drug shortage and build relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages. 

Press Contacts:

 Laura Bray, Angels for Change Chief Change Maker: LauraBray@AngelsforChange.org 

Diane Masiello, Angels for Change Director of Communications: communications@angelsforchange.org